ArticleBMC pharmacology & toxicology2022

Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients.

Karin Yaacoby-Bianu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.